---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-026154"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T09:48:58.572619+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# KemPharm Q3 net loss $0.05/sh; appoints Richard Pascoe as Executive Chairman

## Summary
- Q3 2021 net loss $1.8M ($0.05 per basic share); revenue $2.0M (mostly service fees).
- Cash and equivalents $131.5M at Sep 30, 2021; 35.3M shares outstanding basic.
- Richard W. Pascoe appointed Executive Chairman, effective Nov 10, 2021.
- Pascoe receives $400K base salary, option for 100K shares with performance vesting.
- AZSTARYS commercial launch initiated Jul 21; >50M lives now have access per Corium.

## SEC filing metadata
- accession: 0001437749-21-026154
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/0001437749-21-026154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/kmph20210921_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-026154
- JSON: https://secwatch.observer/filing/0001437749-21-026154.json
- Plain text: https://secwatch.observer/filing/0001437749-21-026154.txt

## Key facts
- Executive change
  Richard W. Pascoe was appointed as Executive Chairman at ZEVRA THERAPEUTICS, INC..
  - Action: appointed
  - Role: Executive Chairman
  source text: On November 5, 2021, the Board of Directors of KemPharm appointed Richard W. Pascoe as KemPharm’s Executive Chairman.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/0001437749-21-026154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.